Session Information
Date: Tuesday, October 28, 2025
Title: (2524–2546) Vasculitis – Non-ANCA-Associated & Related Disorders Poster III
Session Type: Poster Session C
Session Time: 10:30AM-12:30PM
Background/Purpose: Behçet’s syndrome (BS) is a chronic inflammatory disorder characterized by a heterogeneous clinical presentation, occurring primarily in young adults and very rarely in children and adolescents. In addition, there are few studies that compared childhood-onset BS (cBS) and adult-onset BS (aBS), especially in non-endemic regions. Therefore, the objectives of the present study were to evaluate demographic, clinical and therapeutic data in cBS and aBS.
Methods: Medical records of 344 patients [99 cBS (≤ 18 years-old) and 245 aBS] from three tertiary Brazilian Rheumatology centers were reviewed in order to compare clinical and therapeutic features. cBS and aBS were classified according to International Study Group and/or the International Criteria for Behçet’s Disease.
Results: The median age at diagnosis was 11(0.5-17) years in cBS and 30(18-76) years in aBS. The median follow-up time was significantly reduced in cBS compared to aBD [7(0-23) vs. 10(0-27) years, p=0.014], with similar female sex in both groups (56% vs. 62%, p=0.14). Classification criteria were fulfilled in 82% of cBS and 100% of aBS patients. Fever (30% vs. 15%, p=0.002), gastrointestinal involvement (55% vs. 14%, p=0.003), and a family history of autoimmune diseases (22% vs. 16%, p=0.001) were significantly higher in cBS compared to aBS. In contrast, genital ulcers (67% vs. 81%, p=0.01), cutaneous lesions (47% vs. 68%, p=0.001), including pseudofolliculitis (34% vs. 53%, p=0.001) and erythema nodosum (24% vs. 36%, p=0.03), uveitis (32% vs. 44%, p=0.03), corticosteroids (68% vs. 88%, p < 0.001), azathioprine (56% vs. 70%, p=0.01), cyclosporine (9% vs. 22%, p=0.004), cyclophosphamide (19% vs. 34%, p=0.001), and intravenous immunoglobulin use (9% vs. 18%, p=0.03) were significantly lower in the former group. Frequencies of oral and cutaneous ulcers, articular or central nervous system involvement, retinal vasculitis, colchicine, mycophenolate mofetil, and methotrexate use were similar in both groups (p >0.05).
Conclusion: cBS was rarely observed in our non-endemic region, potentially due to under recognition, as it often presented with nonspecific symptoms such as fever and gastrointestinal involvement. The broader spectrum of symptoms in aBS patients might account for the more extensive use of immunosuppressive agents.
To cite this abstract in AMA style:
Machado R, Souza T, França M, Matias V, Farhat S, Siqueira C, Santos M, Steuer L, Forero L, Bassara Macedo R, Freitas T, Bayeh b, Ejnisman C, Araujo P, Cordeiro R, Specian F, Balbi V, Aikawa N, Kozu K, Silva C, Campos L, Elias A, Giardini H. Behçet’s syndrome: distinct features in 344 pediatric and adult patients in a non-endemic region [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/behcets-syndrome-distinct-features-in-344-pediatric-and-adult-patients-in-a-non-endemic-region/. Accessed .« Back to ACR Convergence 2025
ACR Meeting Abstracts - https://acrabstracts.org/abstract/behcets-syndrome-distinct-features-in-344-pediatric-and-adult-patients-in-a-non-endemic-region/